IC
HRTX icon

IEQ Capital’s Heron Therapeutics HRTX Stock Holding History

IEQ Capital’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.6K Buy
66,966
+49,978
+294% +$57.9K ﹤0.01% 1839
2025
Q4 		$22.1K Sell
16,988
-62,037
-79% -$76.6K ﹤0.01% 1825
2025
Q3 		$99.6K Buy
+79,025
New +$125K ﹤0.01% 1766

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

IEQ Capital's HRTX Position: Q1 2026 in Review

IEQ Capital increased its Heron Therapeutics (HRTX) stake by 294% in Q1 2026, buying an estimated $57.9K and bringing the position to 66,966 shares worth $53.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

IEQ Capital first reported a position in HRTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $99.6K in Q3 2025. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • IEQ Capital held 66,966 shares of Heron Therapeutics worth $53.6K as of Q1 2026.
  • IEQ Capital bought 49,978 Heron Therapeutics shares in Q1 2026, an estimated $57.9K.
  • Heron Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1839 holding.
  • IEQ Capital first reported a position in Heron Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • IEQ Capital's Heron Therapeutics position peaked at $99.6K in Q3 2025.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.